JGC
GNMK

J. Goldman & Co’s GenMark Diagnostics, Inc GNMK Stock Holding History

J. Goldman & Co’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-50,000
Closed -$393K – 317
2015
Q3 		$393K Sell
50,000
-250,800
-83% -$2.32M 0.03% 189
2015
Q2 		$2.73M Buy
+300,800
New +$3.03M 0.17% 140

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

J. Goldman & Co's GNMK Position: Q4 2015 in Review

J. Goldman & Co sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2015, closing a stake of 50,000 shares — an estimated $393K sold.

J. Goldman & Co first reported a position in GNMK in Q2 2015 and held it in 2 quarters. The position peaked at $2.73M in Q2 2015. 88 funds tracked by Wall St. Rank hold GNMK as of Q4 2015.

  • J. Goldman & Co reported no remaining GenMark Diagnostics, Inc position as of Q4 2015 after selling out during the quarter.
  • J. Goldman & Co sold 50,000 GenMark Diagnostics, Inc shares in Q4 2015, an estimated $393K.
  • J. Goldman & Co first reported a position in GenMark Diagnostics, Inc in Q2 2015 and held it in 2 quarters.
  • J. Goldman & Co's GenMark Diagnostics, Inc position peaked at $2.73M in Q2 2015.
  • 88 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2015.

Based on J. Goldman & Co's 13F filing for Q4 2015, filed 10 Feb 2016.